Engineered materials for in vivo delivery of genome-editing machinery
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Engineered materials for in vivo delivery of genome-editing machinery
Authors
Keywords
-
Journal
Nature Reviews Materials
Volume 4, Issue 11, Pages 726-737
Publisher
Springer Science and Business Media LLC
Online
2019-10-05
DOI
10.1038/s41578-019-0145-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- One-step generation of modular CAR-T cells with AAV–Cpf1
- (2019) Xiaoyun Dai et al. NATURE METHODS
- Identification of preexisting adaptive immunity to Cas9 proteins in humans
- (2019) Carsten T. Charlesworth et al. NATURE MEDICINE
- Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy
- (2019) Christopher E. Nelson et al. NATURE MEDICINE
- A High-Throughput Platform to Identify Small-Molecule Inhibitors of CRISPR-Cas9
- (2019) Basudeb Maji et al. CELL
- Highly Efficient and Marker-free Genome Editing of Human Pluripotent Stem Cells by CRISPR-Cas9 RNP and AAV6 Donor-Mediated Homologous Recombination
- (2019) Renata M. Martin et al. Cell Stem Cell
- A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune system
- (2019) Martin W. LaFleur et al. Nature Communications
- Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs
- (2019) Liang Qu et al. NATURE BIOTECHNOLOGY
- Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease
- (2019) So Hyun Park et al. NUCLEIC ACIDS RESEARCH
- Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN
- (2018) Christian Hinderer et al. HUMAN GENE THERAPY
- Triple Vectors Expand AAV Transfer Capacity in the Retina
- (2018) Andrea Maddalena et al. MOLECULAR THERAPY
- Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide
- (2018) Hong-Xia Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HPV Oncogene Manipulation Using Nonvirally Delivered CRISPR/Cas9 or Natronobacterium gregoryi Argonaute
- (2018) Yeh-Hsing Lao et al. Advanced Science
- Emerging Issues in AAV-Mediated In Vivo Gene Therapy
- (2018) Pasqualina Colella et al. Molecular Therapy-Methods & Clinical Development
- Therapeutic Genome Editing With CRISPR/Cas9 in a Humanized Mouse Model Ameliorates α1-antitrypsin Deficiency Phenotype
- (2018) Mikael Bjursell et al. EBioMedicine
- Nanoparticle delivery of CRISPR into the brain rescues a mouse model of fragile X syndrome from exaggerated repetitive behaviours
- (2018) Bumwhee Lee et al. Nature Biomedical Engineering
- A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
- (2018) Christopher A. Vakulskas et al. NATURE MEDICINE
- High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population
- (2018) Dimitrios L. Wagner et al. NATURE MEDICINE
- Treatment of a metabolic liver disease by in vivo genome base editing in adult mice
- (2018) Lukas Villiger et al. NATURE MEDICINE
- Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins
- (2018) Philippe E. Mangeot et al. Nature Communications
- Spatial control of in vivo CRISPR–Cas9 genome editing via nanomagnets
- (2018) Haibao Zhu et al. Nature Biomedical Engineering
- A Self-Deleting AAV-CRISPR System for In Vivo Genome Editing
- (2018) Ang Li et al. Molecular Therapy-Methods & Clinical Development
- Unraveling the Complex Story of Immune Responses to AAV Vectors Trial After Trial
- (2017) Céline Vandamme et al. HUMAN GENE THERAPY
- Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects
- (2017) Julien Baruteau et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents
- (2017) Xue Gao et al. NATURE
- RNA targeting with CRISPR–Cas13
- (2017) Omar O. Abudayyeh et al. NATURE
- Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
- (2017) Nicole M. Gaudelli et al. NATURE
- Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions
- (2017) Y Bill Kim et al. NATURE BIOTECHNOLOGY
- Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing
- (2017) Hao Yin et al. NATURE BIOTECHNOLOGY
- Delivery technologies for genome editing
- (2017) Hao Yin et al. NATURE REVIEWS DRUG DISCOVERY
- Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
- (2017) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- In vivo genome editing as a potential treatment strategy for inherited retinal dystrophies
- (2017) Mert Yanik et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Rapid and tunable method to temporally control gene editing based on conditional Cas9 stabilization
- (2017) Serif Senturk et al. Nature Communications
- CRISPR-Mediated Integration of Large Gene Cassettes Using AAV Donor Vectors
- (2017) Rasmus O. Bak et al. Cell Reports
- Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair
- (2017) Kunwoo Lee et al. Nature Biomedical Engineering
- Insertional Mutagenesis by CRISPR/Cas9 Ribonucleoprotein Gene Editing in Cells Targeted for Point Mutation Repair Directed by Short Single-Stranded DNA Oligonucleotides
- (2017) Natalia Rivera-Torres et al. PLoS One
- The Neisseria meningitidis CRISPR-Cas9 System Enables Specific Genome Editing in Mammalian Cells
- (2016) Ciaran M Lee et al. MOLECULAR THERAPY
- Engineered Viruses as Genome Editing Devices
- (2016) Xiaoyu Chen et al. MOLECULAR THERAPY
- Nuclease Target Site Selection for Maximizing On-target Activity and Minimizing Off-target Effects in Genome Editing
- (2016) Ciaran M Lee et al. MOLECULAR THERAPY
- CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
- (2016) Daniel P. Dever et al. NATURE
- Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
- (2016) Alexis C. Komor et al. NATURE
- A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice
- (2016) Yang Yang et al. NATURE BIOTECHNOLOGY
- Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo
- (2016) Hao Yin et al. NATURE BIOTECHNOLOGY
- A multifunctional AAV–CRISPR–Cas9 and its host response
- (2016) Wei Leong Chew et al. NATURE METHODS
- Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems
- (2016) K. Nishida et al. SCIENCE
- C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector
- (2016) Omar O. Abudayyeh et al. SCIENCE
- Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells
- (2016) M. A. DeWitt et al. Science Translational Medicine
- Analysis of nanoparticle delivery to tumours
- (2016) Stefan Wilhelm et al. Nature Reviews Materials
- Physical Principles of Nanoparticle Cellular Endocytosis
- (2015) Sulin Zhang et al. ACS Nano
- Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
- (2015) Bernd Zetsche et al. CELL
- Progress and challenges in viral vector manufacturing
- (2015) Johannes C.M. van der Loo et al. HUMAN MOLECULAR GENETICS
- Drug and gene delivery across the blood–brain barrier with focused ultrasound
- (2015) Kelsie F. Timbie et al. JOURNAL OF CONTROLLED RELEASE
- Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems
- (2015) Sergey Shmakov et al. MOLECULAR CELL
- In vivo genome editing using Staphylococcus aureus Cas9
- (2015) F. Ann Ran et al. NATURE
- Photoactivatable CRISPR-Cas9 for optogenetic genome editing
- (2015) Yuta Nihongaki et al. NATURE BIOTECHNOLOGY
- Therapeutic genome editing: prospects and challenges
- (2015) David Benjamin Turitz Cox et al. NATURE MEDICINE
- Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy
- (2015) C. Long et al. SCIENCE
- In vivo gene editing in dystrophic mouse muscle and muscle stem cells
- (2015) M. Tabebordbar et al. SCIENCE
- Harnessing nanoparticles for immune modulation
- (2015) Daniel R. Getts et al. TRENDS IN IMMUNOLOGY
- Determination of Anti-Adeno-Associated Virus Vector Neutralizing Antibody Titer with anIn VitroReporter System
- (2015) Amine Meliani et al. Human Gene Therapy Methods
- Protein Corona Fingerprinting Predicts the Cellular Interaction of Gold and Silver Nanoparticles
- (2014) Carl D. Walkey et al. ACS Nano
- CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling
- (2014) Randall J. Platt et al. CELL
- Permanent Alteration of PCSK9 With In Vivo CRISPR-Cas9 Genome Editing
- (2014) Qiurong Ding et al. CIRCULATION RESEARCH
- DNA interrogation by the CRISPR RNA-guided endonuclease Cas9
- (2014) Samuel H. Sternberg et al. NATURE
- In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9
- (2014) Lukasz Swiech et al. NATURE BIOTECHNOLOGY
- Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo
- (2014) John A Zuris et al. NATURE BIOTECHNOLOGY
- CRISPR-Cas systems for editing, regulating and targeting genomes
- (2014) Jeffry D Sander et al. NATURE BIOTECHNOLOGY
- Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing
- (2014) Dirk Heckl et al. NATURE BIOTECHNOLOGY
- Multi-kilobase homozygous targeted gene replacement in human induced pluripotent stem cells
- (2014) Susan M. Byrne et al. NUCLEIC ACIDS RESEARCH
- CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences
- (2014) Y. Lin et al. NUCLEIC ACIDS RESEARCH
- High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
- (2013) Yanfang Fu et al. NATURE BIOTECHNOLOGY
- CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity
- (2013) Thomas J. Cradick et al. NUCLEIC ACIDS RESEARCH
- Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis
- (2013) Z. Hou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RNA-Guided Human Genome Engineering via Cas9
- (2013) P. Mali et al. SCIENCE
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
- (2013) Thomas Gaj et al. TRENDS IN BIOTECHNOLOGY
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
- (2011) Carl D. Walkey et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Regulation of Endothelial Permeability via Paracellular and Transcellular Transport Pathways
- (2010) Yulia Komarova et al. Annual Review of Physiology
- Targeting DNA Double-Strand Breaks with TAL Effector Nucleases
- (2010) M. Christian et al. GENETICS
- Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors
- (2010) Sylvie Boutin et al. HUMAN GENE THERAPY
- Permeability of Small Molecules through a Lipid Bilayer: A Multiscale Simulation Study
- (2009) Mario Orsi et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Integration-deficient Lentiviral Vectors: A Slow Coming of Age
- (2009) Klaus Wanisch et al. MOLECULAR THERAPY
- Effect of Genome Size on AAV Vector Packaging
- (2009) Zhijian Wu et al. MOLECULAR THERAPY
- Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: Nanoject
- (2008) Medha Joshi et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection
- (2008) Carmela Zincarelli et al. MOLECULAR THERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started